Effective industry and research collaboration: addressing the intellectual property challenge
David Chuter
Manufacturer’s Monthly
March 2020
Centralised manufacture of Molecularly Targeted Radiation (MTR) Drugs for cancer treatment
Providing better access to life-changing treatments for cancer patients
Army deployed as manufacturers ramp up production
Australian Financial Review
24 March 2020
Clinical trial paves way for “micro patch” vaccine delivery
Vaxxas’ micro-needle patch has potential to deliver enhanced immune response, quicker and at a lower dose
Radiation drugs with longer shelf life bring hope for cancer patients globally
Manufacturing research to increase the shelf-life of radiation drugs